This dual action provides extra support for appetite control and energy use, making it especially helpful for individuals requiring broader metabolic support
If you are considering whether to stop semaglutide abruptly versus tapering, that decision should be medical, not based on running out of medication
2019;11:eaau4760
For weight management, NHS treatment is typically initiated within specialist weight management services, with specific BMI thresholds, comorbidity requirements, and continuation criteria that must be met
Unlike tirzepatide, Ozempic and Wegovy are GLP-1 agonists, which means they target only one receptor
Understanding Pancreatitis as a Potential Side Effect Evidence Linking GLP-1 Agonists to Pancreatitis Risk Recognising Symptoms of Pancreatitis During Treatment When to Seek Medical Advice and Safety Precautions Scientific References Frequently Asked Questions What Are GLP-1 Agonists and How Do They Work